Scholar Rock Holding Net Debt Growth & History (SRRK)
Scholar Rock Holding's net debt was −$214.6M for fiscal 2025.
View full Scholar Rock Holding company overviewScholar Rock Holding annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$214.6M | −$101.9M | — |
| 2024 | 2024-12-31 | −$112.8M | −$72.7M | — |
| 2023 | 2023-12-31 | −$40.0M | −$6.2M | — |
| 2022 | 2022-12-31 | −$33.9M | $101.9M | — |
| 2021 | 2021-12-31 | −$135.8M | −$32.6M | — |
| 2020 | 2020-12-31 | −$103.2M | −$72.2M | — |
| 2019 | 2019-12-31 | −$31.0M | $84.0M | — |
| 2018 | 2018-12-31 | −$115.0M | −$59.0M | — |
| 2017 | 2017-12-31 | −$56.1M | — | — |
Scholar Rock Holding quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$233.3M | −$141.9M | — |
| Q1 2026 | 2026-03-31 | −$224.9M | −$150.1M | — |
| Q4 2025 | 2025-12-31 | −$214.6M | −$101.9M | — |
| Q3 2025 | 2025-09-30 | −$176.7M | −$166.9M | — |
| Q2 2025 | 2025-06-30 | −$91.4M | −$66.1M | — |
| Q1 2025 | 2025-03-31 | −$74.8M | −$42.9M | — |
| Q4 2024 | 2024-12-31 | −$112.8M | −$72.7M | — |
| Q3 2024 | 2024-09-30 | −$9.8M | −$5.7M | — |
| Q2 2024 | 2024-06-30 | −$25.3M | $17.3M | — |
| Q1 2024 | 2024-03-31 | −$31.9M | $51.9M | — |
| Q4 2023 | 2023-12-31 | −$40.0M | −$6.2M | — |
| Q3 2023 | 2023-09-30 | −$4.1M | $56.8M | — |
| Q2 2023 | 2023-06-30 | −$42.7M | $189.2M | — |
| Q1 2023 | 2023-03-31 | −$83.8M | −$59.1M | — |
| Q4 2022 | 2022-12-31 | −$33.9M | $101.9M | — |
| Q3 2022 | 2022-09-30 | −$60.9M | $61.5M | — |
| Q2 2022 | 2022-06-30 | −$231.9M | −$80.3M | — |
| Q1 2022 | 2022-03-31 | −$24.7M | $78.7M | — |
| Q4 2021 | 2021-12-31 | −$135.8M | −$32.6M | — |
| Q3 2021 | 2021-09-30 | −$122.4M | −$99.1M | — |
| Q2 2021 | 2021-06-30 | −$151.6M | −$41.2M | — |
| Q1 2021 | 2021-03-31 | −$103.4M | −$13.0M | — |
| Q4 2020 | 2020-12-31 | −$103.2M | −$72.2M | — |
| Q3 2020 | 2020-09-30 | −$23.3M | $3.8M | — |
| Q2 2020 | 2020-06-30 | −$110.4M | −$2.3M | — |
| Q1 2020 | 2020-03-31 | −$90.4M | −$29.4M | — |
| Q4 2019 | 2019-12-31 | −$31.0M | $84.0M | — |
| Q3 2019 | 2019-09-30 | −$27.1M | $76.3M | — |
| Q2 2019 | 2019-06-30 | −$108.1M | $6.3M | — |
| Q1 2019 | 2019-03-31 | −$61.0M | — | — |
| Q4 2018 | 2018-12-31 | −$115.0M | −$59.0M | — |
| Q3 2018 | 2018-09-30 | −$103.4M | — | — |
| Q2 2018 | 2018-06-30 | −$114.3M | — | — |
| Q4 2017 | 2017-12-31 | −$56.1M | — | — |
Scholar Rock Holding net debt trends
Over the last five fiscal years, Scholar Rock Holding's net debt decreased from −$103.2M to −$214.6M, a change of −$111.4M. The latest reported quarter, Q2 2026, shows −$233.3M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scholar Rock Holding source filings ↗Community posts
Scholar Rock wins FDA approval for muscle-targeted SMA treatment
Scholar Rock ($SRRK) received FDA approval for ISEMBYLD, its apitegromab treatment for spinal muscular atrophy, in patients aged two and older receiving SMN2-targeted therapy. The company plans to begin shipping the medicine within days. Th ...